Strong revenue growth, profit collapse — metering cash crisis unresolved
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Prior FY26 call guidance: '2x market growth' (maintained at 40% growth vs 17% market). Pushed cash positive target from FY26 year-end to FY27 year-end (one-year delay).
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Revenue growth sustained at 40.5%, order book ₹9,000 Cr strong, new verticals (OSAT/PCB, space) strategically sound. BUT delivered PAT crashed -24.4% despite 40% topline growth, NPM compressed to 5.9%, OCF negative ₹259 Cr. Metering receivables crisis (₹1,311 Cr) unresolved; management defers concrete fix to Q3. OSAT/PCB unproven at scale (₹1,200 Cr capex, limited revenue yet). Margin compression from component inflation (30–35%) will persist 2–3 quarters. Risk: year-end cash positive target (pushed from FY26) depends on OSAT/PCB acceleration and metering receivables recovery, both uncertain.
₹946 Cr
Revenue · +40.5% YoY₹56.4 Cr
Reported PAT · −24.4% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
EMS business grew 48% standalone; overall 40% YoY growth
METOverall revenue ₹946 Cr, +40.5% YoY. Standalone EMS ₹639 Cr (+53% vs ₹480 Cr prior), metering ₹204 Cr (-12%). Blended growth 40.5%.
EBITDA margin 15.6%, up 31% YoY despite cost inflation
OVERSTATEDEBITDA ₹147.6 Cr, 15.6% OPM confirmed. But NPM collapsed -24.4% to 5.9%, driven by depreciation (OSAT/PCB capex), lost QIP income (~2.5% impact), and component cost pass-through lagging.
Cash flow improvement vs prior year (negative ₹259 Cr vs ₹379 Cr prior Q1)
METOCF negative ₹259 Cr (inventory +₹177 Cr strategic, receivables short +₹68 Cr). Improved QoQ but still severely negative, risking year-end cash positive target.
Metering business flat to negative as deliberate strategic degrwoth
MISSMetering revenue ₹204 Cr (-12% YoY). Receivables exploded ₹1,158 Cr → ₹1,311 Cr (+₹153 Cr, +13%). Got ₹200 Cr collections in first July week (after quarter). No concrete model fix; exploring divestment, promised update in Feb call.
On track for OSAT/PCB commercial revenue Q3/Q4 FY27
METCapex ₹1,200 Cr spent (₹700 OSAT, ₹500 PCB). Validation complete for one customer (semicon logic), trials ongoing (OSAT). West Asia logistics caused minor timing slippage. Target ₹450–500 Cr FY27 full-year. Timeline credible but unproven.
Earnings quality
What changed since the last call
Cash positive target delayed
DowngradeFY26 call committed 'cash positive by year-end.' Now deferred to FY27 year-end. Q1 OCF -₹259 Cr vs ₹379 Cr prior, still deeply negative.
Metering WC unresolved
DowngradeReceivables blew out ₹1,158 Cr → ₹1,311 Cr despite degrowth. Prior call promised resolution; now exploring divestment, no concrete timeline.
Revenue guidance removed
NeutralPrior calls suggested 30–35% growth; now only commit '2x market growth.' (Market at 17% Q1, so implies 34%, which Kaynes hit at 40.5% EMS). Cited volatility.
Margin compression acknowledged
DowngradeNPM fell to 5.9% (-24.4% YoY). Management expects 'couple of quarters' for normalization. Cost inflation (PCB 3x, components 30–35%) won't reverse.
OSAT/PCB timing on track
NeutralMinor West Asia logistics slippage mentioned, but target Q3/Q4 FY27 commercialization reaffirmed. Validation progressing (one customer done, another in trials).
The Q&A
Analysts pressed hard on margin bridge (Renu Baid), OCF bridge (Siddhartha), metering strategy (Santhosh, multiple follow-ups). Management answered OCF directly but with caveats (inventory strategic). Dodged absolute margin recovery timelines and metering fix—deferred to future calls. Defended cost inflation as industry-wide, industry-wide, cited pass-through, but admitted 'difficult year.' No major pushback on OSAT/PCB timeline; confidence there held up.
EMS growth breakdown — Renu Baid, IIFL Capital
PartialOverall EMS 40%, metering 28%, blended 48%. Margin hit by depreciation (OSAT/PCB capex), lost QIP income ~2.5%, cost escalation. Normalization in 2 quarters.
Metering divestment — Renu Baid, IIFL Capital
DodgedConsidering options, methodology TBD. Will update in Feb earnings call on de-risk strategy. Management serious on options.
OSAT/PCB timeline — Renu Baid, IIFL Capital
AnsweredCommercial revenue from Q3 FY27, on track. Trials/validation complete for semicon logic, OSAT validation starting. Customers approved vendor codes.
Operating cash flow — Siddhartha Bera, Nomura
AnsweredOCF -₹259 Cr (inventory +₹177 Cr strategic, receivables +₹68 Cr short). Metering sales ₹204 Cr. New orders ₹1,500 Cr (no breakdown given). Q1 FY26 OCF was -₹379 Cr.
OSAT/PCB capex — Siddhartha Bera, Nomura
AnsweredTotal ₹1,200 Cr spent (₹700 OSAT, ₹500 PCB), plus ₹250 Cr in transit. FY27 plan ₹300 Cr OSAT + ₹300 Cr PCB, but modular based on subsidies/customer needs.
Metering business model — Santhosh Seshadri, Avendus Spark
PartialMetering manufacturing + installation/service (8-year ops). Kaynes strong in manufacturing. Exploring divestment of service portion separately; working on model, will update Q3. Enough order book to have controlled growth.
Metering service model shift — Santhosh Seshadri, Avendus Spark
DodgedDone all pre-work, studying partnerships, nothing concrete. Will have clear idea Q3 onwards, maybe not next quarter.
Receivables, payables, debt — Achal Lohade, Nuvama
AnsweredReceivables ₹1,765 Cr (start) → ₹1,925 Cr (end). EMS ₹606 → ₹613 Cr (stable). Metering ₹1,158 → ₹1,311 Cr (↑₹153 Cr). Inventory 96 days → 105 days. OCF -₹259 Cr (or -₹235 Cr consolidated depending on definition).
FY27 revenue guidance — Achal Lohade, Nuvama
DodgedCommitted 2x market growth (market 17% Q1, so ₹34%+ internal). Won't commit absolute FY27 number due to volatility. OSAT/PCB FY27 ₹450–500 Cr, internal vs external TBD per business math.
Component cost inflation — Praveen Sahay, PL Capital
AnsweredPCB up 3x, components 30–35% but only 10–12% specific inflation. Forex headwind ~3.3% EBITDA impact Q1. Pass-through Q-o-Q, not immediate. Cost escalation (consumables, labor, energy) ongoing. Pricing pass-on lagging.
Gross margin compression outlook — Praveen Sahay, PL Capital
PartialDifficult year, but will meet requirements. It's a tough year. Not easy, but will manage. Top lines up, bottom lines affected (per RBI/market view).
Capex guidance FY27/FY28 — Inderjeet Agarwal, CLSA India
AnsweredFY27: ₹300 Cr OSAT, ₹300 Cr PCB, ₹250 Cr EMS. Q1 spent ₹230 Cr all in. Flexible for newer business/subsidies. Funding not a constraint.
PCB margins/ROC — Inderjeet Agarwal, CLSA India
DodgedToo early to discuss. Last quarter (H2 FY26) PCB companies did fairly well. Crisis only 3–4 months old. Top lines up, bottom lines affected per market view. Won't commit margins.
Inventory, payables, debt, tax — Sonali Salgaonkar, Jefferies India
AnsweredInventory 105 days (strategic increase Feb). Debt ~₹800 Cr, D/E 0.3x. Effective tax rate company 23%, consolidated 35% (amortization 3%, Semicon/Circuits intercompany interest 5%, loss-making entities 4%).
OSAT/PCB off-take geography — Sonali Salgaonkar, Jefferies India
DodgedCan't name customers. General: both domestic and global customer engagement ongoing. No specific breakdown given.
Net debt reconciliation — Aditya Bhartia, Investec India
PartialOperating CF -₹235 Cr (consolidated). Cash profit ₹158 Cr, inventory +₹156 Cr, receivables +₹90 Cr, others +₹145 Cr, tax ₹26 Cr. Fixed assets ₹360 Cr, investment ₹317 Cr, financing ₹263 Cr. Working with numbers.
Margin pressure and pass-through mechanics — Aditya Bhartia, Investec India
PartialChallenging time, need balance between offset and growth. Service customer or fail. Strategic top customers have agreements on how to move forward. Will ensure minimum impact but timing delays expected. Faster than peers in industry.
Order book composition — Praveen Sahay, PL Capital
PartialDon't give segment splits. Very strong order book >₹8,900 Cr (added more Q1 than opened/delivered). Strong demand across domestic/global despite inflation. No cuts from PSU/government.
Guidance
2x market growth (restated commitment)
MediumMarket grew 17% Q1; Kaynes overall 40%, EMS 48% — on track. Won't commit absolute FY27 number citing volatility. Implies ~34%+ if market stays 17%.
OSAT/PCB FY27 ₹450–500 Cr
MediumTarget for full-year FY27 combined, starting Q3. Capex ₹1,200 Cr spent to date, funding continuing. Customer validation progressing; Mitsui partnership + global EV customer contract close to finalization.
Profitability normalization in 2–3 quarters
LowLost ~2.5% PBT/PAT from QIP income (non-recurring). Depreciation elevated (OSAT/PCB capex), cost inflation (30–35% components, PCB 3x) expected to persist. Pass-through Q-o-Q lagging.
No absolute margin targets, only trajectory
LowManagement acknowledged 'difficult year' but avoided committing to OPM/NPM recovery levels. Defensive tone suggests near-term margin pressure continues.
FY27 ₹300 Cr OSAT, ₹300 Cr PCB, ₹250 Cr EMS
HighStated commitment. Q1 spent ₹230 Cr (₹90 OSAT, ₹90 PCB, ₹50 EMS). Modular expansion if subsidies/customer wins accelerate. Funding not a constraint.
Risks the call surfaced
Metering receivables
HighReceivables ₹1,311 Cr (+13% q-q), collections only ₹88 Cr on ₹240 Cr sales. Business deliberately degrown due to WC constraints. Model unresolved; exploring divestment but no concrete strategy or timeline.
Operating cash flow
HighOCF -₹259 Cr Q1 (inventory +₹177 Cr strategic, receivables +₹68 Cr). Improved vs -₹379 Cr prior Q1 but still severely negative. Cash positive by FY27 year-end target now at risk if OSAT/PCB ramp delays or metering receivables persist.
Margin compression
HighNPM collapsed -24.4% YoY to 5.9% despite 40% revenue growth. Driven by depreciation (OSAT/PCB capex), lost QIP income (~2.5%), cost inflation (components 30–35%, PCB 3x). Pass-through lagging Q-o-Q. Management acknowledges 'difficult year' but won't commit recovery timeline or levels.
OSAT/PCB execution risk
MediumCapex ₹1,200 Cr spent to date (₹700 OSAT, ₹500 PCB, ₹250 Cr in transit). Revenue minimal to date. Target ₹450–500 Cr FY27 full-year from Q3/Q4 commercialization. Customer validation ongoing (one done, another in trials). If ramp delays or demand softens, capex ROI at risk. West Asia logistics disruption cited as cause of minor timing slippage.
Customer concentration (metering)
MediumMetering business 60–65% manufacturing, 35–40% service/installation (long-tail 8-year government contracts). Government utilities primary customer base; collections slow and sporadic. Flood disruptions also affecting installations. If government policy shifts or utility budgets cut, metering revenue at risk.
Management
Score 6/10. Candid on failures (metering WC, cost inflation, capex depreciation impact). Evasive on metering fix strategy (deferred to Q3), absolute FY27 guidance (avoided citing volatility). Transparent on working capital bridge, cash flow waterfall. Numbers often qualified or approximate ('around ₹800 Cr debt'). Met 40% YoY revenue growth (2.4x market 17%). Missed profitability (-24.4% PAT despite 40% topline). Pushed cash positive target one year (FY26 → FY27). OSAT/PCB on track Q3/Q4 timeline but unproven at scale. Metering strategy unresolved 2+ years.
1 · Q2 FY27 (Oct 2026)
OSAT/PCB commercial production start, first revenue bookings expected
2 · Q3 FY27 (Jan 2027)
Metering strategy reset announcement (promised in Feb call, but deferred to Q3 visibility)
3 · H2 FY27
Component inflation pass-through to customers, margin recovery if pricing sticks
Risk: year-end cash positive target (pushed from FY26) depends on OSAT/PCB acceleration and metering receivables recovery, both uncertain.
Kaynes Q1 FY27: consolidated PAT down 24% YoY to ₹56 Cr despite 40% revenue growth
PAT -24.38% YoY · revenue +40.47% · margins compressing · miss vs street
₹946.02 Cr
+40.47% YoY
₹56.43 Cr
-24.38% YoY
5.87%
-4.8pp YoY
₹8.42
Kaynes Technology's consolidated Q1 FY27 (quarter ended June 30, 2026) print is a clear YoY miss on profitability despite strong topline growth: consolidated PAT fell 24.4% YoY to ₹56.4 Cr against revenue growth of 40.5% YoY to ₹946.0 Cr. Street consensus (Univest's 22-analyst poll) had modeled PAT near ₹94 Cr on ~₹939 Cr revenue — the top line came in essentially in line, but PAT missed by roughly 40%, a sharp disappointment relative to expectations. Kotak Institutional Equities had flagged a 30% YoY revenue growth path with a possible 220bps margin hit from a lower smart-meter mix; revenue actually outran that estimate, but the margin damage was concentrated well below the operating line rather than at the OPM level Kotak was watching.
Q1 FY-2027 vs prior quarters
The gap between the topline strength and the profit miss sits almost entirely below EBITDA. Depreciation more than doubled YoY to ₹37.0 Cr (+136.8%) and finance costs rose 30.6% to ₹37.1 Cr, both consistent with the OSAT and PCB capacity management flagged coming online this year; even before tax, PBT actually declined 8.6% YoY to ₹87.9 Cr despite the 40% revenue growth. Tax then compounded the hit: the tax expense rose 46.5% YoY to ₹31.45 Cr as the deferred-tax credit that had cushioned last year's number shrank, lifting the effective tax rate to 35.8% from 22.4% a year ago. Operating margin held up comparatively well — OPM eased only to 15.6% from 16.8% YoY and was roughly flat sequentially versus Q4 FY26's 15.58% — but net margin compressed nearly 480bps YoY to 5.9% from 10.7%, showing the squeeze is a capex/tax story more than a core operating-cost story.
The stock went into the print at ₹3,856.3, up 12.5% over the past month of trading.
What the summary numbers don't show
Sequentially, revenue fell 23.9% and PAT fell 38.1% QoQ from a seasonally strong Q4 FY26 (₹1,242.6 Cr revenue) — a normal seasonal slowdown, not a fresh deterioration signal on its own.
Management declined to provide specific revenue guidance, instead committing to 'double the market growth rate' (market growth estimated at 16-18%). A key focus is on resolving the severe negative operating cash flow, with a commitment to reverse the trend in the smart metering business within three quarters and turn t
— This quarter: beat
Notably, standalone (parent-only) PAT grew 41.7% YoY to ₹76.9 Cr, the opposite direction of the consolidated number — a divergence readers should not mistake for an error. The auditors' limited-review report shows the nine India-based subsidiaries combined for a modest ₹11.3 Cr net profit and the eight foreign subsidiaries were roughly breakeven for the quarter, indicating the drag sits in the newer, capex-heavy units (OSAT, PCB, Semicon, and the smart-meter business) still absorbing depreciation and finance costs ahead of scale. On guidance, the 40.5% YoY revenue growth clears management's Q4 FY26 commitment to grow at 'double the market rate' (market pegged at 16-18%, implying a ~32-36% bar) — a beat on that specific marker. Management's separate commitment to turn overall company cash flow positive by year-end and reverse negative operating cash flow in smart metering within three quarters cannot be checked from this filing, which contains no cash-flow statement; no press release or management commentary accompanied this filing to cross-check tone. The board also approved Walker Chandiok & Co LLP as incoming statutory auditor and allotted 1,87,837 ESOP shares — routine governance items, not drivers of the print.
W1
Effective tax rate trajectory — jumped to 35.8% this quarter from 22.4% a year ago on a shrunk deferred-tax credit; watch Q2 FY27 for normalization.
W2
Operating cash flow — management committed on the Q4 FY26 call to turn overall cash flow positive by year-end and reverse negative OCF in smart metering within three quarters; unverifiable from this filing (no cash-flow statement), next quarter is the checkpoint.
W3
OSAT (₹250-300 Cr target) and PCB (₹300-400 Cr target) ramp-up — watch segment disclosure to see if these lines keep pushing depreciation/finance costs ahead of EBITDA growth.
40% growth, 24% profit loss — the capex bill comes due
Kaynes delivered 40% revenue growth but profit crashed 24% to ₹56.4 Cr, driven by OSAT/PCB capex depreciation, metering receivables drag, and component inflation. Guidance maintained but pushed back one year — a signal of execution caution.
₹946 Cr
+40.5% YoY, +2.4x market growth
₹56.4 Cr
-24.4% YoY, NPM 5.9%
-₹259 Cr
vs -₹379 Cr prior Q1, improving but severe
₹639 Cr
+53% YoY growth
The real tension: growth divorced from profit
Kaynes hit 40% revenue growth—a genuine achievement—but net profit collapsed 24% to ₹56.4 Cr, slashing net margins to 5.9%. This is not a market miss or demand shock. It is capex in execution mode: the company is absorbing ₹1,200 crore in OSAT/PCB depreciation (with minimal revenue yet), cost inflation (components 30–35%, PCB 3x), lost QIP investment income (~2.5% of PAT), and the drag from metering receivables (₹1,311 Cr, collections only ₹88 Cr on ₹240 Cr sales). Management's tone is candid: 'a difficult year,' with normalization promised in 2–3 quarters. The market disagreed—stock down 5% by day 5, with FII and DII both trimming.
Where the profit went (and what does not come back)
Start with ₹147.6 Cr EBITDA (15.6% OPM), flat to prior. Then subtract: (a) Depreciation surge from ₹700 Cr OSAT + ₹500 Cr PCB capex, (b) Lost QIP investment income ~₹12–15 Cr (no longer available—one-time cliff), (c) Component inflation pass-through lag—PCB cost up 3x, semiconductors 30–35%, pricing hasn't caught up Q-o-Q, (d) Metering receivables drag—business deliberately degrown to preserve cash, but collections only 37% of sales, (e) Forex headwind ~3.3% EBITDA impact. The cascade lands PAT at ₹56.4 Cr. What management controls: OSAT/PCB timeline and customer ramp (on track for Q3/Q4 FY27 revenue, but unproven). What it doesn't: component pricing and government payment timelines for metering.
EMS business grew 48% standalone; overall 40% YoY growth demonstrates market leadership
EMS ₹639 Cr (+53% YoY), August Electronics ₹102 Cr (+327%, acquired Jul 2025). Metering ₹204 Cr (-12%). Blended 40.5% confirmed. Market growth 17%, so 2.4x outperformance real.
Supported
EBITDA margin 15.6%, up 31% YoY despite cost inflation
EBITDA 15.6% OPM confirmed. But NPM crashed -24.4% to 5.9%, driven by depreciation (capex), lost QIP, component cost pass-through lagging. Gross margin compression evident but buried.
Overstated (margin quality)
Cash flow improved vs. prior year (negative ₹259 Cr vs ₹379 Cr prior Q1)
OCF -₹259 Cr (inventory +₹177 Cr strategic, receivables +₹68 Cr short). Improved vs prior but still severely negative. Got ₹200 Cr metering collections in July (timing issue). Year-end cash positive target at risk.
Supported (but unsustainable)
On track for OSAT/PCB commercial revenue Q3/Q4 FY27; validation complete for one customer
Capex ₹1,200 Cr spent (₹700 OSAT, ₹500 PCB). Semicon logic validation done, OSAT trials ongoing. West Asia logistics minor slippage noted. Target ₹450–500 Cr FY27 full-year credible but unproven.
Supported (execution risk remains)
Metering business is strategically degrown; exploring de-risk models (divestment, service split)
Metering revenue ₹204 Cr (-12%). Receivables exploded ₹1,158 Cr → ₹1,311 Cr (+13% q-q) despite degrowth. No concrete model fix; 'exploring' and 'will update Q3.' Deferred twice already.
Contradicted (no resolution path)
What changed on this call
Cash positive target delayed one year. FY26 guidance: 'cash positive by year-end.' Now: 'by end of FY27 year-end.' Q1 OCF -₹259 Cr, still deeply negative. Metering strategy unresolved. Two-year problem now in its third year; no decision announced. Revenue guidance reframed. Prior calls: '30–35% growth.' Now: '2x market growth' (same math, different framing, avoids absolute commitment). Margin recovery vague. NPM fell to 5.9% (-24.4% YoY); promised 'couple of quarters' normalization but zero targets attached. OSAT/PCB timing held. Q3/Q4 FY27 commercialization reaffirmed; validation progressing; Mitsui partnership (Japan access) + global EV customer contract imminent.
How the street is positioned—and what it is saying
Price action speaks disappointment. Stock closed at ₹3,660 on day 7 (result announced day 1 at ₹3,856.30). Day-1 drop -3.14%, day-5 drop -5.09%—the market voted the quarter soft despite headline growth. The stock is now -47.7% off its all-time high, trading below its 200-day average (₹4,029.96), above the 50-day (₹3,371.15), RSI 69 (neutral). Volume normal. Institutional flows confirm skepticism. FII trimmed -1.46 percentage points to 5.82% (from 7.28% last quarter), DII -3.36pp to 11.78% (from 15.14%). Both are exiting. Promoters hold steady at 53.46%. The tape does not lie: growth at this price (and amid this execution risk) is not attractive enough to hold.
40% revenue growth, 2.4x market rate—leadership validated
EMS core business +53% standalone; August Electronics +327% (acquired); new logos in aerospace, defense, railways
Order book ₹9,000 Cr strong, added more in Q1 than delivered, no customer cuts from PSU/govt
Strategic capex (OSAT/PCB, space tech with ISRO/DRDO) opens high-margin verticals
Government subsidy ₹170 Cr (OSAT) received, de-risks capex funding
PAT crashed -24.4% despite 40% revenue—profitability utterly decoupled from growth
NPM compressed to 5.9% from ~8–10% prior; depreciation + cost inflation + QIP loss
Metering receivables exploded ₹1,311 Cr (+13% q-q) despite degrowth; collections only 37% of sales
Operating cash flow -₹259 Cr, severely negative; year-end cash positive target pushed one year
OSAT/PCB capex ₹1,200 Cr spent with minimal revenue; ROI unproven, timeline depends on Q3/Q4 ramp
Component inflation (30–35%, PCB 3x) pass-through lagging; margin pressure continues 2–3 quarters
Metering model unresolved two years; no concrete exit plan, 'exploring' vague commitment
Management tone shifted to 'difficult year'; defensive on margins, evasive on metering
FII/DII both trimmed post-result; promoters hold steady
Metering receivables crisis (₹1,311 Cr)—no concrete exit plan
HighBusiness deliberately degrown but receivables exploded +13% q-q. Collections only 37% of sales. Problem unresolved for two years; divestment/service split only options, no timeline. If recovery slips, balance sheet deteriorates further.
Profitability decoupling—-24.4% PAT despite 40% revenue growth
HighMargin compression from capex depreciation, cost inflation (30–35%), and QIP loss (~2.5%) is structural, not cyclical. Management's 'couple quarters' normalization promise lacks credibility—cost pressures will not reverse on their own.
Operating cash flow negative -₹259 Cr; year-end cash positive target at risk
HighCompany burning cash despite strong topline. Inventory hedge (+₹177 Cr strategic) and metering receivables drag (+₹68 Cr) tie up liquidity. If OSAT/PCB ramp delays or metering collections slip further, year-end target (already pushed once) becomes unachievable.
OSAT/PCB capex ROI unproven (₹1,200 Cr capex, minimal revenue to date)
HighCompany has bet ₹1,200 Cr (total), with ₹250 Cr more in transit and ₹600 Cr planned for FY27. Target ₹450–500 Cr FY27 revenue is entry-level. If commercialization slips past Q3/Q4 FY27 or customer demand softens, capex returns deteriorate sharply.
Component inflation (30–35%, PCB 3x)—pass-through delayed, pricing power weak
MediumIndustry-wide pressure, but Kaynes' customers are demanding. Pass-through lagging Q-o-Q; management admits 'difficult year.' Larger peers have margin power Kaynes may lack. If pricing power does not improve, margin compression persists into FY28.
Guidance vagueness—no absolute FY27 revenue target, only % commitments
MediumPrior calls hinted 30–35% growth; now only '2x market growth' restated. Avoids accountability. If market slows to 12–15%, 2x becomes 24–30%—sounds good but signals management flexibility (i.e., optionality, not commitment).
FII/DII outflows post-result; valuation at risk if growth disappoints
MediumInstitutional quality check failed. FII -1.46pp, DII -3.36pp, both trimming. Stock is -47.7% off ATH and below 200-day average. If growth stalls or capex ROI disappoints, stock has limited support.
1 · Q2 FY27: OSAT/PCB first revenue bookings and gross margin bridge
Does Q3/Q4 FY27 timeline hold? Do customer trials (semicon logic, OSAT) convert to actual orders? Gross margin Q2—is component inflation pass-through tracking or lagging further?
2 · Q3 FY27: Metering de-risk strategy announcement (promised in Feb call, deferred once)
Service model split, divestment, or restructure? Concrete timeline and financial impact. If another deferral, credibility zero.
3 · H2 FY27 cash flow: Does negative OCF trend reverse or persist?
Metering receivables (₹1,311 Cr)—are collections accelerating? Inventory strategic buffer (+₹177 Cr)—is it being absorbed into revenue or still dragging? Year-end cash positive target: achievable or deferred again?
The honest read
Kaynes is executing on a long-term strategy: build OSAT/PCB capacity (₹1,200 Cr capex), expand into space/aerospace/defense, grow EMS domestically (+53%, +2.4x market). The architecture is sound, and the order book (₹9,000 Cr) backs it. But this quarter showed execution risk, not opportunity. Profit collapsed despite growth (a mark of distress, not strength), metering receivables remain unresolved two years in, and management deflected on both the margin recovery path and the metering exit. Guidance was maintained but reframed (avoiding absolute targets) and key timelines were pushed (cash positive FY26 → FY27). The market's reaction—down 5% by day 5, FII/DII both exiting—reflects a fair judgement: the growth premium has been shed, and the company must now prove execution, not just articulate it.
This is a Steady quarter, not a step-change. The single number to track from here is net cash flow in H2 FY27—if metering collections and inventory absorption accelerate, the year-end cash positive target holds and confidence restores. If not, another year-end push signals structural stress, not temporary depreciation headwind. Until then, the bear case (capex ROI unproven, receivables unresolved, margin pressure persistent) outweighs the bull case (strategic initiatives, order book, topline growth).